Dementia among elderly apolipoprotein E type 4/4 homozygotes: A prospective study
- 1 January 1995
- journal article
- research article
- Published by Wiley in Genetic Epidemiology
- Vol. 12 (3) , 309-311
- https://doi.org/10.1002/gepi.1370120308
Abstract
The E*4 allele of the apolipoprotein E (APOE) gene on chromosome 19 has been shown to be an age- and dose-related risk factor for Alzheimer's disease. Of 870 elderly women participating in an osteoporosis study, 13 were previously found to be homozygous for the APOE*4 allele; 1 was deceased and the rest were assessed for dementia in a “piggyback” study of dementia. One had moderate [clinical dementia rating (CDR) = 2], 2 had mild dementia (CDR = 1), and 2 had possible dementia (CDR = 0.5). All 3 women over 80 years were definitely demented (CDR ⩾ 1). Typically, genetic studies of Alzheimer's and other dementias require the identification and diagnosis of large numbers of demented subjects, at considerable expense, followed by genotyping or phenotyping with a relatively low yield of individuals with rare alleles. We demonstrate a more cost-effective approach in which the population is first phenotyped and then stratified by phenotype, so that diagnostic evaluation can be restricted to individuals with the phenotype of interest. ©1995 Wiley-Liss, Inc.Keywords
This publication has 6 references indexed in Scilit:
- Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseThe Lancet, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Sensitivity and Specificity for Dementia of Population-Based Criteria for Cognitive Impairment: The MoVIES ProjectJournal of Gerontology, 1993
- Apo E allele frequencies in younger (age 42–50) vs older (age 65–90) womenGenetic Epidemiology, 1993
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982
- “Mini-mental state”Journal of Psychiatric Research, 1975